Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Heng

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
A novel Pd-catalyzed cyclization reaction of ureas for the synthesis of dihydroquinazolinone p38 kinase inhibitorsAchim Schlapbach, Richard Heng, Franco Di Padova
Academic Radiology|July 17, 2025
Documenting Disclosure: Limited Reporting of Generative AI Usage in Radiology Research ManuscriptsD Jonah Barrett, Richard Heng, Jordan D Perchik
ACS Medicinal Chemistry Letters|April 20, 2018
Modulating ADME Properties by Fluorination: MK2 Inhibitors with Improved Oral ExposureJuraj Velcicky, Achim Schlapbach, Richard Heng, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2010
Novel 3-aminopyrazole inhibitors of MK-2 discovered by scaffold hopping strategyJuraj Velcicky, Roland Feifel, Stuart Hawtin, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2008
Pyrrolo-pyrimidones: a novel class of MK2 inhibitors with potent cellular activityAchim Schlapbach, Roland Feifel, Stuart Hawtin, et al.
Bioorganic & Medicinal Chemistry Letters|October 4, 2005
Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritisLaszlo Revesz, Birgit Bollbuck, Thomas Buhl, et al.
Current Topics in Medicinal Chemistry|April 14, 2004
New highly potent and selective adenosine A(3) receptor antagonistsNeil J Press, Thomas H Keller, Pamela Tranter, et al.
Bioorganic & Medicinal Chemistry Letters|July 3, 2010
In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part ILaszlo Revesz, Achim Schlapbach, Reiner Aichholz, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2018
N-aryl-piperidine-4-carboxamides as a novel class of potent inhibitors of MALT1 proteolytic activityAchim Schlapbach, Laszlo Revesz, Carole Pissot Soldermann, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
A novel Pd-catalyzed cyclization reaction of ureas for the synthesis of dihydroquinazolinone p38 kinase inhibitorsAchim Schlapbach, Richard Heng, Franco Di Padova
Academic Radiology|July 17, 2025
Documenting Disclosure: Limited Reporting of Generative AI Usage in Radiology Research ManuscriptsD Jonah Barrett, Richard Heng, Jordan D Perchik
ACS Medicinal Chemistry Letters|April 20, 2018
Modulating ADME Properties by Fluorination: MK2 Inhibitors with Improved Oral ExposureJuraj Velcicky, Achim Schlapbach, Richard Heng, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2010
Novel 3-aminopyrazole inhibitors of MK-2 discovered by scaffold hopping strategyJuraj Velcicky, Roland Feifel, Stuart Hawtin, et al.
Bioorganic & Medicinal Chemistry Letters|October 24, 2008
Pyrrolo-pyrimidones: a novel class of MK2 inhibitors with potent cellular activityAchim Schlapbach, Roland Feifel, Stuart Hawtin, et al.
Bioorganic & Medicinal Chemistry Letters|October 4, 2005
Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritisLaszlo Revesz, Birgit Bollbuck, Thomas Buhl, et al.
Current Topics in Medicinal Chemistry|April 14, 2004
New highly potent and selective adenosine A(3) receptor antagonistsNeil J Press, Thomas H Keller, Pamela Tranter, et al.
Bioorganic & Medicinal Chemistry Letters|July 3, 2010
In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part ILaszlo Revesz, Achim Schlapbach, Reiner Aichholz, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2018
N-aryl-piperidine-4-carboxamides as a novel class of potent inhibitors of MALT1 proteolytic activityAchim Schlapbach, Laszlo Revesz, Carole Pissot Soldermann, et al.
Pageof 1